Xtacy Therapeutics Corp (XTCY.CX)
0.03
0.00 (0.00%)
CAD |
CNSX |
May 07, 11:15
Xtacy Therapeutics Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.0218M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | 0.0242M |
| June 30, 2020 | 0.0267M |
| March 31, 2020 | 0.0343M |
| December 31, 2019 | 0.0166M |
| September 30, 2019 | 0.0015M |
| June 30, 2019 | 0.0655M |
| March 31, 2019 | 0.017M |
| December 31, 2018 | 0.0284M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 |
| Date | Value |
|---|---|
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | 0.0007M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.0015M
Minimum
Sep 2019
0.0655M
Maximum
Jun 2019
0.0272M
Average
0.0242M
Median
Sep 2020
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.2658M |
| Total Expenses (Quarterly) | 0.2658M |
| EPS Diluted (Quarterly) | -0.01 |
| Enterprise Value | 1.381M |
| Earnings Yield | -66.67% |
| Normalized Earnings Yield | -64.02 |